CD8A and diabetes mellitus: To this end, we used diabetogenic 8.3-CD8+ T effector cells expressing the TCRαβ receptor of islet-derived diabetogenic CD8+ T cell clones of NOD mice that contribute to beta cell destruction and diabetes development [37,38].